Abstract
The incidence of prostate cancer is gradually increasing. There are many methods for clinical treatment of prostate cancer, such as surgical treatment and endocrine treatment. In the case of advanced prostate cancer, we must not only extend patients' survival times but also enhance their quality of life. Endocrine medications are the most effective therapy for advanced prostate cancer. This research will investigate the therapeutic impact of a complete treatment model in prostate cancer in order to discover a trustworthy clinical treatment model. This research discovered that, as compared to endocrine treatment, radical resection of prostate cancer may diminish and reach lower serum PSA levels in a short amount of time, as well as sustain low PSA levels and delay progression to castration resistance. Moreover, the comprehensive treatment mode can effectively reduce the possibility of complications. The research results show that the comprehensive treatment model can play an important role in the treatment of prostate cancer.
Highlights
Prostate cancer is the most common malignant tumor in Europe
This paper explores the role of comprehensive treatment models in the treatment of prostate cancer, and provides a theoretical reference for the subsequent treatment effects of prostate cancer
The standard is based on AJCC 2010 version of prostate cancer TNM staging
Summary
Prostate cancer is the most common malignant tumor in Europe. China’s prostate cancer ranks third in the male genitourinary system malignant tumor bureau. The western medicine treatment strategy for prostate cancer bone metastasis pain is mostly analgesics, but as the illness progresses and adverse responses to analgesics become more common, the effectiveness and usage of analgesics are substantially impacted. The treatment of bone metastasis pain of prostate cancer is often supplemented by traditional Chinese medicine to improve the symptoms of patients and improve their quality of life, which has shown gratifying therapeutic effects. In the United States, the incidence of prostate cancer ranks first among male malignant tumors and ranks second among male cancer-related death rates. The rate of increase in the incidence of prostate cancer in China has even surpassed that of developed countries in Europe and America. This paper explores the role of comprehensive treatment models in the treatment of prostate cancer, and provides a theoretical reference for the subsequent treatment effects of prostate cancer
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
